Cardinal Health (NYSE: CAH) updates 2026 EPS outlook, J.P. Morgan plans

Rhea-AI Filing Summary

Cardinal Health, Inc. reported that it has updated its previously issued fiscal year 2026 non-GAAP earnings per share outlook. This means the company has revised its internal expectations for how much profit per share it plans to generate, after adjusting for certain items.

The company also highlighted its upcoming appearance at the 44th Annual J.P. Morgan Healthcare Conference, scheduled for January 13 at 9:00 a.m. Pacific Standard Time. Additional details are provided in a news release issued on January 13, 2026 and attached as an exhibit.

Insights

Equity research analyst

Cardinal Health revised its 2026 non-GAAP EPS outlook and flagged a major conference appearance.

Cardinal Health updated its fiscal 2026 non-GAAP earnings per share outlook, signaling a change in management’s expectations for adjusted profitability. While the direction and magnitude of the change are not included here, any alteration to forward EPS outlook can influence how investors assess future earnings power.

The company also pointed to its participation in the 44th Annual J.P. Morgan Healthcare Conference on January 13, a high-profile industry event where management typically discusses strategy and business trends. Subsequent access to the attached news release and conference commentary will be important for understanding the specifics behind the updated outlook.

0000721371false00007213712026-01-132026-01-13

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 13, 2026

Cardinal Health, Inc.

(Exact name of registrant as specified in its charter)

Ohio

1-11373

31-0958666

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

7000 Cardinal Place, Dublin, Ohio 43017

(614) 757-5000

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common shares (without par value)			CAH			New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   p

Item 7.01: Regulation FD Disclosure

On January 13, 2026, Cardinal Health, Inc. (the “Company”) issued a press release announcing, among other things, an update to its previously issued fiscal year 2026 non-GAAP earnings per share outlook. The release also contains information about the Company’s upcoming appearance at the 44th Annual J.P. Morgan Healthcare Conference, which is scheduled for January 13 at 9:00 a.m. Pacific Standard Time. A copy of the news release is attached to this Form 8-K as Exhibit 99.1.

Item 9.01: Financial Statements and Exhibits

(d) Exhibits

Exhibit Number			Exhibit Description
99.1			News release issued by the Company on January 13, 2026

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Cardinal Health, Inc.

(Registrant)

Date:

January 13, 2026

By:

/s/ AARON E. ALT

Aaron E. Alt

Chief Financial Officer

FAQ

What did Cardinal Health (CAH) update in this 8-K?

Cardinal Health updated its previously issued fiscal year 2026 non-GAAP earnings per share outlook, indicating a revised view of expected adjusted profitability.

Does the Cardinal Health (CAH) filing include specific 2026 EPS numbers?

The content states that Cardinal Health updated its fiscal year 2026 non-GAAP EPS outlook, but the specific figures are contained in the attached news release, not in this text.

What conference is Cardinal Health (CAH) participating in?

Cardinal Health plans to appear at the 44th Annual J.P. Morgan Healthcare Conference, scheduled for January 13 at 9:00 a.m. Pacific Standard Time.

When was the Cardinal Health (CAH) news release issued?

The company issued its news release on January 13, 2026, and it is attached as Exhibit 99.1.

Which SEC item does Cardinal Health (CAH) use for this disclosure?

The update to the fiscal 2026 non-GAAP EPS outlook and conference information are presented under Item 7.01: Regulation FD Disclosure.

Who signed the Cardinal Health (CAH) report?

The report was signed on behalf of Cardinal Health by Aaron E. Alt, Chief Financial Officer.